A biotech company, LambdaVision, is developing artificial retinas made in space to treat retinal diseases, leveraging microgravity to improve quality. The retinal layers use a light-activated protein to mimic natural photoreceptors. Supported by NASA, LambdaVision aims to advance to clinical trials after successful preclinical development.













